Baxter International Inc., a global medtech leader, will present at the Goldman Sachs 43rd Annual Global Healthcare Conference on Tuesday, June 14, 2022. José (Joe) Almeida, Baxter’s chairman and chief executive officer, is scheduled to present at 10:40 a.m. Pacific Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through June 13, 2023. About Baxter Every day, mi

ChromaDex Corp., announced a partnership with Juvenis to conduct cross-border sales of Tru Niagen® in South Korea. Juvenis is a Korean healthcare marketing company with a focus on the cosmetic and dietary supplement industries. With strong partnerships in a dynamic and trend-setting Korean market, Juvenis emphasizes products with differentiated science and proven benefits. Tru Niagen® is one of Amazon’s top-selling brands in the Vitamin B3 category for boosting NAD+ le

Camber Spine, a leading innovator in spine and medical technologies has announced that it is entering into the next phase of the complete national launch of the SPIRA-P Posterior Lumbar Spacer and has recently commercialized its Spira-T Oblique Posterior Lumbar Spacer. Part of Camber’s SPIRA product platform, the SPIRA-P Posterior Lumbar Spacer is versatile to accommodate open and minimally invasive PLIF or TLIF procedures and features a patented open architecture design for o

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host a groundbreaking ceremony for its new manufacturing facility in Malaysia, further strengthening its global manufacturing capabilities. “We are taking an important step to further diversify globally and ensure our valued customers continue to have uninterrupted access to our life-changing products,” said Chuck Alpuche, Insulet Executive Vice Presid

For the first time, scientists have found that brain differences in the visual brain systems of infants who later are diagnosed with autism are associated with inherited genetic factors. Published in the American Journal of Psychiatry, this research shows that brain changes in the size, white matter integrity and functional connectivity of the visual processing systems of six-month olds are evident well before they show symptoms of autism as toddlers. Moreover, the presence of brain

MediCardia Health Inc., a pioneer in global digital health, announced today that the Company has completed integration with Optimize EP's CaRM CIED (cardiovascular implantable electronic device) platform. The combined platform will comprise the worlds 1st comprehensive connected cardiac care platform for management of patients chronic cardiovascular conditions and cardiac implanted devices. As a partner, Optimize EP will provide comprehensive CIED data to support the MediCardia Virtuas re

Melax Tech, a world leader in AI-powered software provider of biomedical natural language processing (NLP) technology, announced today the partnership with Vanderbilt University Medical Center (VUMC), one of the largest academic medical centers in the Southeast as their official NLP technology provider. This partnership will provide the de-identification of VUMC clinical notes to promote the secondary use of EHRs for the Vanderbilt research community. "We are grateful to VUMC f

Continuing their commitment to the advancement of life sciences in North Carolina, Azzur Cleanrooms on DemandTM, a market-leading provider for early-phase life sciences GxP manufacturing, celebrated the opening of its latest facility in Morrisville, NC with a widely-attended ground-breaking ceremony. Event attendees included representatives of the Wake County Government Board of Commissioners, Town of Morrisville, and Morrisville Chamber of Commerce, as well as local business leader

RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, announced today that it has received FDA 510(k) clearance for its Rapid PE Triage & Notification product for fast identification and communication of suspected central pulmonary embolism — further strengthening RapidAI’s industry-leading clinical AI platform. New research shows that death rates for pulmonary embolism have been on the rise over the last

PanTher Therapeutics (PanTher), a clinical-stage oncology company developing next-generation targeted therapies for solid tumors, today announced that a methods-of-use patent for a deployable anticancer drug-eluting stent, exclusively licensed to PanTher, has been issued by the United States Patent and Trademark Office (USPTO). The patent increases the potential applicability of PanTher’s proprietary Sagittari™ treatment platform, which focuses on direct, localized, and sustained